Melanoma Clinical Trials Database - Free Access to 716 Studies
Access comprehensive clinical trial information for Melanoma through Pure Global AI's free database. This collection includes 716 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 120 trials are actively recruiting participants.
Research for Melanoma is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Bristol-Myers Squibb and M.D. Anderson Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Etude rétrospective Monocentrique MATRIX
LATe TreatmENT Related Toxicity in Melanoma (LATENT)
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
ctDNA for Early Detection of Recurrence in Melanoma
Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma
A Study of IBI363 in Subjects With Advanced Melanoma
Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response
Untitled Trial
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
Pure Global AI provides free access to 716 clinical trials studying Melanoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Bristol-Myers Squibb, M.D. Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, among others.